STOCK TITAN

Biodesix chairman acquires 1,360 shares via conversion

After conversion, John Patience reported direct holdings of 26,743 common shares and 1,361 RSUs.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Biodesix Inc. chairman and director John Patience converted 1,360 restricted stock units (RSUs) into 1,360 common shares on September 30, 2026. Each RSU represents a contingent right to receive one common share. The RSUs vest in four substantially equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026, generally subject to continued service.

Insider PATIENCE JOHN
Role Director
Type Security Shares Price Value
Exercise Restricted Stock Units F1, F4 1,360 $0.00 $0.00
Exercise Common Stock F1 1,360 -- --
holding Common Stock F2 -- -- --
holding Common Stock F3 -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Restricted Stock Units — 1,361 contracts (Direct); Common Stock — 26,743 shares (Direct); Common Stock — 107,664 shares (Indirect, By Patience Enterprises LP); Common Stock — 241,480 shares (Indirect, By John Patience Living Trust dated 7/23/1993); Common Stock — 2,649 shares (Indirect, By Spouse)
Footnotes (4)
  1. F1. Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock ("Common Stock").
  2. F2. The Reporting Person is the sole general partner of Patience Enterprises LP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
  3. F3. The Reporting Person is the sole trustee of John Patience Living Trust (July 23, 1993).
  4. F4. These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
RSUs converted 1,360 RSUs September 30, 2026
Common shares acquired 1,360 shares Through RSU conversion on September 30, 2026
Direct common shares after transaction 26,743 shares September 30, 2026
RSUs after transaction 1,361 RSUs September 30, 2026
Common shares held by Patience Enterprises LP 107,664 shares Indirect holdings as of September 30, 2026
Common shares held by John Patience Living Trust 241,480 shares Indirect holdings as of September 30, 2026
Spouse's common shares 2,649 shares Indirect holdings as of September 30, 2026
restricted stock unit financial
"Each restricted stock unit"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
vest financial
"These RSUs vest in four substantially equal installments"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
beneficial ownership regulatory
"disclaims beneficial ownership of these securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest regulatory
"to the extent of his pecuniary interest therein"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many BDSX shares did John Patience acquire?

On September 30, 2026, John Patience converted 1,360 restricted stock units into 1,360 common shares. Each RSU represents a contingent right to receive one common share.

What vesting schedule applies to John Patience's BDSX RSUs?

The RSUs vest in four substantially equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026, generally subject to John Patience's continued service with Biodesix Inc.

What indirect BDSX holdings are listed for John Patience?

As of September 30, 2026, reported indirect common-stock positions included 107,664 shares held by Patience Enterprises LP, 241,480 shares by John Patience Living Trust dated July 23, 1993, and 2,649 shares by his spouse. Patience was the LP's sole general partner and the trust's sole trustee; he disclaimed beneficial ownership of the LP securities except to the extent of his pecuniary interest.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
PATIENCE JOHN

(Last)(First)(Middle)
919 WEST DILLON RD

(Street)
LOUISVILLE COLORADO 80027

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
BIODESIX INC [ BDSX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)XOther (specify below)
Chairman
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/30/2026M1,360A(1)26,743D
Common Stock107,664IBy Patience Enterprises LP(2)
Common Stock241,480IBy John Patience Living Trust dated 7/23/1993(3)
Common Stock2,649IBy Spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)09/30/2026M1,360 (4) (4)Common Stock1,360$01,361D
Explanation of Responses:
1. Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock ("Common Stock").
2. The Reporting Person is the sole general partner of Patience Enterprises LP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
3. The Reporting Person is the sole trustee of John Patience Living Trust (July 23, 1993).
4. These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
/s/ Robin H. Cowie as Attorney-in-Fact for John Patience10/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading